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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYAdvances in induced pluripotent stem cell (iPSC) technology have set the stage for routine derivation of patient- and disease-specific hu-
man iPSC-cardiomyocyte (CM)models for preclinical drug screening and personalizedmedicine approaches. Peripheral bloodmononu-
clear cells (PBMCs) are an advantageous source of somatic cells because they are easily obtained and readily amenable to transduction.
Here, we report that the electrophysiological properties and pharmacological responses of PBMC-derived iPSCCMare generally similar to
those of iPSC CM derived from other somatic cells, using patch-clamp, calcium transient, and multielectrode array (MEA) analyses.
Distinct iPSC lines derived from a single patient display similar electrophysiological features and pharmacological responses. Finally,
we demonstrate that human iPSC CMs undergo acute changes in calcium-handling properties and gene expression in response to rapid
electrical stimulation, laying the foundation for an in-vitro-tachypacing model system for the study of human tachyarrhythmias.INTRODUCTION
The reprogramming of somatic cells to induced pluripo-
tent stem cells (iPSCs) has revolutionized the fields
of biology and medicine, providing new avenues for
research and regenerative medicine applications. IPSCs
are typically generated from somatic cells by overexpres-
sion of a set of pluripotency-specific transcription factors
(Takahashi et al., 2007; Takahashi and Yamanaka, 2006;
Yu et al., 2007). For many years, the fibroblast has been
the main source from which to derive human iPSCs
(hIPSCs), and numerous publications have described the
functional properties of cardiomyocytes (CMs) differenti-
ated from fibroblast-derived iPSCs (Itzhaki et al., 2011,
2012; Lahti et al., 2012; Liang et al., 2013; Malan et al.,
2011; Matsa et al., 2011; Moretti et al., 2010; Navarrete
et al., 2013; Yazawa et al., 2011). Disadvantages of fibro-
blasts, however, as a somatic cell source include the
need for a minor surgical procedure (skin biopsy) and
the requirement for several weeks of expansion prior to
reprogramming (Lowry et al., 2008). To overcome these
hurdles, Staerk and colleagues developed an approach to
generate hiPSCs from peripheral blood T and myeloid
cells that allows for transduction shortly after harvesting
(Staerk et al., 2010).
Here, we report the electrophysiological and pharmaco-
logical characterization of CMs differentiated from human
peripheral blood mononuclear cell (PBMC)-derived iPSCs,
using the patch-clamp technique, calcium transient (CaT)
measurements, andmultielectrode array (MEA) recordings.SteMEA-based assays using hiPSC-derived CMs are an attrac-
tive platform for the preclinical evaluation of potential
QT-prolonging drug effects, a major obstacle in drug devel-
opment, and the prevention of adverse outcomes. Most
hiPSCCM studies report the field potential duration as a
measure of repolarization, although this measure has no
direct correlate to the transmembrane action potential
duration (APD). The activation-recovery interval (ARI) is a
direct correlate of APD and has been extensively validated
in animal models and human studies (Chinushi et al.,
2001; Fuller et al., 2000a; Haws and Lux, 1990; Yue et al.,
2004). In this study, we report the ARI as a robust, spatio-
temporal measure of repolarization particularly when
applied to the effects of pharmacological treatment of
hiPSC CM in culture. Such proof-of-principal experiments
provide a platform to study the (patho)physiological
interactions between the initiating factors and the sub-
strates underlying human tachyarrhythmias and to test
the in vitro efficacy of Food and Drug Administration-
approved therapeutic interventions.RESULTS
Derivation of hiPSC Lines and Proof of Pluripotency
PBMC transduction with lentiviral STEMCCA vectors
generated multiple iPSC clones. Of ten iPSC clones gener-
ated, three were selected for subsequent characterization
and differentiation into CMs (Figures 1 and 2). Transduced
cells grew in typically shaped colonies and resembledm Cell Reports j Vol. 3 j 131–141 j July 8, 2014 j ª2014 The Authors 131
Figure 1. Characterization of Human
Peripheral Blood Monocyte-Derived iPSCs
(A) Representative image of iPSC colonies
in bright field. Scale bar, 200 mm.
(B) Representative images of iPSC colonies
after immunostaining for the pluripotency
markers NANOG, SSEA-4, OCT-4, and TRA-1-
81. The merged images additionally include
a DAPI staining for DNA to show that the
transcription factors and pluripotency
markers NANOG and OCT-4 are localized
within the nuclei of the cells. Scale bars,
100 mm.
(C) Pluripotency gene expression levels as
revealed by quantitative real-time PCR.
Gene expression levels of undifferentiated
hiPSCs (gray bars) are very similar to those of the undifferentiated human H9 cells (black bars). hB53 controls (Co) (uninfected blood
mononuclear cells) show practically no pluripotency gene expression levels (white bars) (n = 3 independent experiments). Error bars, SD.
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Evaluation of metaphase cells from the colonies revealed
a normal male chromosome karyotype. To establish the
pluripotency of the generated hiPSC lines, we first analyzed
the mRNA expression levels of the endogenous OCT-4,
SOX2, NANOG, and TRA-1-60 expression levels with RT-
quantitative PCR (qPCR) (Figure 1C). Expression of the
tested genes was significantly higher in hB53 iPSCs
compared with parental PBMCs. Moreover, the gene
expression levels of iPSCs were similar to the human ESC
line H9. Accordingly, immunocytochemistry staining of
hiPSCs revealed that human stem cell marker proteins
such as NANOG, SSEA4, OCT4, and TRA-1-81 were highly
expressed in iPSCs (Figure 1B).
Next, we tested the ability of iPSC lines to form tissues
of all three embryonic germ layers in mice. Subcutaneous,
intramuscular, and intratesticular injections of six iPSC
lines were performed in immunodeficient mice. Teratoma
formation was observed 4–8 weeks later. Histological
evaluation of the tumors revealed abundant differentiation
into epithelia of all three embryonic germ layers. Fig-
ure 2B shows representative images of respiratory ciliated
epithelium (endoderm), cartilage epithelium (mesoderm),
and pigmented neuroectodermal epithelium (ectoderm).
The in-vivo-derived tumors showed endodermal-specific
markers a-fetoprotein and GATA4, the mesodermal-spe-
cific markers a-major histocompatibility complex (MHC)
and BRACHYURY, and ectodermal-specific markers b-III-
tubulin and vimentin (Figure 2A).
Cardiac Differentiation
Spontaneously beating clusters of cells first appeared
around day 7 postinitiation of differentiation using the
matrix sandwich protocol (see Experimental Procedures).
By flow cytometry, 65%–90% of cells stained positive for132 Stem Cell Reports j Vol. 3 j 131–141 j July 8, 2014 j ª2014 The Authorsa-actinin at 15 days postdifferentiation (Figure 3A). Immu-
nocytochemistry staining of hiPS-CM revealed the typical
pattern of sarcomeric structures and organization (Fig-
ure 3B). Further functional characterization of the hiPSC
CM is described in the following sections.
Electrophysiological Properties of Single CMs
Differentiated from PBMC iPSCs
Action potentials (APs) were recorded from single-beating
CMs between 30 and 50 days postdifferentiation using
the disrupted patch technique (see Experimental Proce-
dures). Similar to cardiac myocytes differentiated from
human ESCs and human fibroblast-derived iPSCs (Itzhaki
et al., 2011; Lahti et al., 2012; Liang et al., 2013; Navar-
rete et al., 2013; Yazawa et al., 2011), myocytes differen-
tiated from PBMC-derived iPSCs demonstrated distinct
AP properties that can be arbitrarily categorized as
nodal-, atrial-, and ventricular-like (Figure 4). Nodal-like
myocytes were characterized by a more depolarized
maximum diastolic potential (MDP) and slower upstroke
velocity compared with atrial- and ventricular-like myo-
cytes. Atrial-like myocytes were distinguished by shorter
APD and slower upstroke velocities compared to ventric-
ular-like myocytes. Ventricular-like myocytes displayed
the longest APD (measured at 10%, 50%, and 90% of
repolarization), lowest resting membrane potential, and
the fastest upstroke velocities. All three types of myocytes
displayed spontaneous beating at similar cycle lengths.
The spontaneous depolarization and relatively depolar-
ized MDP of the iPSC-derived myocytes are consistent
with the immature nature of these cells and are similar
to the properties described for myocytes differentiated
from ESC lines and fibroblast-derived iPSCs (Itzhaki
et al., 2011; Lahti et al., 2012; Liang et al., 2013; Navar-
rete et al., 2013; Yazawa et al., 2011). The sample size of
Figure 2. Ability of Human PBMC-Derived iPSCs to Differen-
tiate into Cells of All Three Embryonic Germ Layers
(A) Quantification of the expression of representative genes of the
three embryonic germ layers. The relative expression of AFP, GATA4
(both endoderm), a-MHC, BRACHYURY (both mesoderm), b-III-
tubulin, and vimentin (both ectoderm) is shown in relation to
undifferentiated hiPSCs from the same patient. Error bars, SD (n = 4
independent experiments).
(B) Teratoma, derived from hiPSCs comprising cell types of all three
embryonic germ layers. Representative images show respiratory
ciliated epithelium (endoderm), cartilage epithelium (mesoderm),
and pigmented neuroectodermal epithelium (ectoderm). Scale bar,
100 mm.
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small and therefore may not represent the true distribu-
tion of CM subtypes.
Electrophysiological Properties of CM Monolayers
Differentiated from PBMC iPSCs
To assess the electrical coupling of the hiPSC-derived CMs,
we seeded terminally differentiated CMs onMEA chambers
and measured spontaneous cycle length, repolarization
properties, and conduction velocity in three iPSC lines
derived from patient hB53 (Figure 5A). Local electrograms
revealed high-fidelity depolarization and repolarization
waves that allowed for the precise measurement of the
ARI and conduction velocity across the array (Figure 5A).
Analysis of all 60 electrograms combined allowed for cre-
ation of isochronal maps of activation time (AT), ARI, and
conduction velocity across the array (Figures 5B and 5C;
Figure S1 available online). There were no differences in
spontaneous cycle lengths and conduction velocities be-
tweenmyocytes from the three iPSC lines. Moreover, there
was no difference inmeanARI values between arrays plated
withmyocytes differentiated from three distinct iPSC lines.SteHowever, as expected for a heterogeneous population of
myocytes, there was heterogeneity in repolarization across
the array, as measured by the ARI. The ARI measurement is
a direct correlate of APD50 (see Discussion; Chinushi et al.,
2001; Fuller et al., 2000b; Haws and Lux, 1990) and thus is
comparable to the APD50 values listed in Figure 4 (70, 137,
and 310 ms for nodal-, atrial-, and ventricular-like cells,
respectively, compared to the mean ARI of 180 ms). The
mean ARI value observed is a composite value that likely
reflects electrotonic coupling between individual cells of
varying APD. We previously showed that direct coupling
of myocytes of varying AP morphology and APD results
in an intermediate, composite AP (Spitzer et al., 1997).
However, the relative contribution of chamber-specificmy-
ocytes to the mean ARI cannot be definitively ascertained
by MEA analysis.
Next, we tested the effects of various antiarrhythmic
agents on the electrophysiological properties of iPSC CM
(Figure 6). Lidocaine (LIDO) caused a dose-dependent
prolongation of repolarization that was reversible with
washout. The higher LIDO concentrations (R100 mM)
likely caused a block of rapidly activating delayed rectifier
potassium current (IKr) that, in turn, resulted in delayed
repolarization. LIDO also resulted in progressive slowing
of conduction velocity, confirming the role of Na+ chan-
nels in impulse propagation in hiPSC-derived CMs.
Although conduction velocity achieved statistical signifi-
cance only for the 100 mM dose, there was a trend toward
slower velocity at higher LIDO concentrations, compared
to control. Dofetilide caused a dose-dependent prolonga-
tion of the ARI, underscoring an important role for IKr
in meditating repolarization in CMs differentiated from
PBMC-derived iPSCs. Higher concentrations of dofetilide
induced secondary depolarizations indicative of early-after
depolarizations (EADs) (Figure S2). The effects of dofetilide
were irreversible (data not shown). Diltiazem caused dose-
dependent shortening of repolarization and a marked in-
crease in spontaneous cycle length. The diltiazem-induced
slowing of spontaneous beating indicates a role for L-type
Ca2+ in firing rate, as is typical for pacemaker cells and
embryonic CMs. Finally, amiodarone did not alter repolar-
ization, spontaneous cycle length, or conduction velocity
even at concentrations up to 1 mM. The dose-dependent
drug effects were similar within myocytes derived from
the three iPSC lines. Taken together, these data demon-
strate that cardiomyocytes differentiated from PBMC-
derived iPSCs display electrophysiological characteristics
of immature myocytes, respond to prototypical antiar-
rhythmic agents in an expected manner, and behave
similar to myocytes differentiated from fibroblast-derived
iPSCs. Moreover, myocytes differentiated from distinct
iPSC lines from a single patient share similar electrophysi-
ological properties and drug responses.m Cell Reports j Vol. 3 j 131–141 j July 8, 2014 j ª2014 The Authors 133
Figure 3. Human PBMC-Derived iPSCs
Give Rise to Functional CMs
(A) High percentage of a-actinin-posi-
tive cells. After differentiation, cells were
stained for the cardiac marker protein
a-actinin and analyzed by a flow cytometer.
Depending on the hiPSC line, up to 87% of
the cells were positive for a-actinin (line
hB53 hiPS6). Error bars, SD (n = 3 inde-
pendent experiments).
(B) Representative images of troponin T-
and a-actinin-stained hiPSC-derived CMs.
Scale bars, 10 mm (upper panel) and 30 mm
(lower panel).
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Remodeling in Cultured CMs Differentiated from
Human PBMC-Derived iPSCs
Next, we tested the effects of rapid electrical stimulation
(tachypacing) on calcium handling in CMs differentiated
from human PBMC-derived iPSCs in culture. CM clusters
were stimulated at 1 and 4 Hz for 1, 4, 8, and 12 hr. CMs
did not tolerate 12 hr of electrical stimulation at a rate of
4 Hz. These cells developed blebbing of the cell membrane
by light microscopy and were not further analyzed. No
differences in CaT parameters were detected in myocytes
stimulated for 4 hr compared to nonpaced control cells
(Figure S3). However, rapid stimulation at 4 Hz for 8 hr
dramatically reduced Ca2+ transientmagnitude and slowed
the rate of transient decay, compared to cells paced at 1 Hz
and unpaced controls (Figure 7). In addition, CaTs recorded
from cells stimulated at 4 Hz for 8 hr displayed abnormal
secondary Ca2+ releases. Rapid electrical stimulation
reduced L-type Ca2+ channel transcripts, as measured by
real-time qPCR. These results indicate that hiPSC CMs un-
dergo acute electrical remodeling in response to tachypac-
ing, similar to that described in other in vitro and in vivo
models of tachycardia.DISCUSSION
The ability to generate patient-specific CMs from somatic
cells is revolutionizing the study of cardiovascular diseases
and holds tremendous promise for drug discovery, toxi-
cology screening, and personalized medicine approaches.
Although a skin biopsy to obtain dermal fibroblasts
is considered minimally invasive, a blood draw is a far
simpler and more acceptable approach to obtain somatic
cells for reprogramming, especially in the pediatric popula-
tion. Although the majority of reprogramming studies
have focused on fibroblasts as the somatic cell source,
several studies have recently demonstrated the feasibility
of reprogramming PBMCs. IPSCs derived from PBMCs134 Stem Cell Reports j Vol. 3 j 131–141 j July 8, 2014 j ª2014 The Authorshave been successfully differentiated into mesenchymal
stems cells, hepatocytes, and CMs (Brown et al., 2010;
Churko et al., 2013; Sommer et al., 2012; Staerk et al.,
2010). However, to date, there has been no comprehensive
characterization of the electrophysiological properties
of CMs differentiated from human PBMC-derived iPSCs.
Here, we describe the electrophysiological and pharmaco-
logical characterization of CMs differentiated from human
PBMC-derived iPSCs.
CMs differentiated from PBMC-derived iPSCs demon-
strated the typical AP features and morphologies consis-
tent with nodal-, atrial-, and ventricular-like phenotypes.
The specific electrophysiological features, including MDP,
upstroke velocity, and APD10, APD50, and APD90, for
the three cell typeswere generally similar to values reported
for CMs differentiated from fibroblast-derived iPSCs and
ESCs (Itzhaki et al., 2011; Lahti et al., 2012; Liang et al.,
2013; Navarrete et al., 2013; Yazawa et al., 2011). We
were surprised at the similarity in AP parameters given
the distinct source of somatic cells and differences in the
experimental conditions. These observations suggest that
despite the reported differences in epigenetic memory be-
tween different somatic cell sources, the electrophysiolog-
ical behavior of the differentiated human CMs remains
remarkably similar.
MEAs offer the potential for moderate-throughput
characterization of the electrophysiological and pharmaco-
logical properties of iPSC-derived CMs. Analysis of the
pharmacological effects of various antiarrhythmic agents
provides additional insight into the underlying electro-
physiology of these CMs. For example, the slowing of con-
duction velocity by LIDO indicates an essential role for Na+
channels in impulse propagation, an important feature
of mature CMs. Moreover, the sensitivity of diltiazem to
slow the spontaneous cycle length is consistent with the
known role for L-type Ca2+ channels in modulating pace-
maker activity. Interestingly, we found no specific alter-
ations in the measured electrophysiological parameters
in response to increasing concentrations of amiodarone.
Figure 4. APs Recorded from CMs Differentiated from Human
PBMC-Derived iPSCs
(A) Representative APs recorded from individual myocytes dis-
playing nodal-, atrial-, and ventricular-like phenotypes.
(B) Table displaying AP parameters for the three subtypes of CMs.
CL, cycle length (s); MDP, in mV; Pmax, maximum upstroke velocity
(mV/ms); APD10, APD50, or APD90, APD at 10%, 50%, or 90% of
repolarization (ms). Values are mean ± SEM. *p < 0.05 (ANOVA with
Bonferroni correction). All three subgroups were different from
each other for the measured parameters, except CL, where only
atrial- and ventricular-like groups were statistically different. The
‘‘n’’ listed in the table represents independent recordings from CMs
differentiated from iPSC line C1.
Stem Cell Reports
Functional Analysis of iPSC CardiomyocytesAlthough considered a class III antiarrhythmic agent,
amiodarone’s effects are complex and vary with respect to
acute and chronic administration. There is considerable
variation in the degree of APD modulation induced by
acute exposure to amiodarone, with reports of shortening,
prolongation, and no effect on APD (Kodama et al., 1997).
Acute amiodarone blocks inward Na+ and Ca2+ currents as
well as delayed rectifier K+ currents, and some of the effects
are rate dependent (Kato et al., 1988; Kodama et al., 1996).
We speculate that themultiple channel and receptor-block-
ing effects of amiodarone result in competing effects that
ultimately cause no net change in our measured MEA
parameters. Finally, ARI prolongation and the induction
of triggered depolarizations by dofetilide underscore the
importance of IKr in repolarization of CMs.
The pharmacological effects of antiarrhythmic agents in
PBMC-derived iPSCCMs described here are similar to those
reported for CMs differentiated from fibroblast-derived
iPSCs (Braam et al., 2013; Liang et al., 2013; Navarrete
et al., 2013). These observations further support the notion
that epigenetic memory based on the somatic cell source
may not have important functional consequences for
iPSC-derived CMs, with respect to basic electrophysiology.
Whether epigenetic memory plays an important role in
other physiologic or metabolic processes remains to be
determined. In addition, we found that individual iPSC
lines derived from the same patient displayed similar elec-Stetrophysiological features and pharmacological responses.
These findings have important implications for deter-
mining how many cell lines are necessary for proper
characterization of disease-specific iPSC-based models of
cardiovascular disease.
MEA-based analyses are an important tool to characterize
patient- or disease-specific responses to pharmacological
interventions and provide a platform for in vitro preclinical
screening for QT interval-prolonging drugs. As such,
proper measurement of repolarization is critical for the ac-
curate determination of risk assessment for drug develop-
ment and a mechanistic understanding of arrhythmia
models. The extracellular field potential is determined by
the transmembrane currents that shape the AP of individ-
ual cells within the vicinity of the electrode. However,
the currently accepted standard measures of repolarization
do not precisely relate to local repolarization at the level of
the transmembrane AP. For example, most published stem
cell-derivedmyocyte studies report the time at the ‘‘end’’ of
the repolarization wave (field potential duration), as if one
were measuring the end of a Twave on a surface electrocar-
diogram (ECG) (Itzhaki et al., 2011, 2012; Lahti et al., 2012;
Liang et al., 2013; Malan et al., 2011; Matsa et al., 2011;
Moretti et al., 2010; Navarrete et al., 2013; Yazawa et al.,
2011). Alternatively, the time to peak of the repolarization
wave is reported (Zwi et al., 2009). Although bothmeasure-
ments track repolarization in a general sense, neither re-
flects an accurate correlate of local APD. Moreover, despite
the lack of any data supporting its applicability, the Bazett
correction factor is often applied to the field potential dura-
tion measurement to correct for cycle length changes.
By contrast, the ARI is an establishedmeasure of local repo-
larization that has been extensively validated in animal
models and human studies, using simultaneously acquired
intracellular recordings and monophasic APD recordings
(Ajijola et al., 2013; Chinushi et al., 2001; Compton
et al., 1996; Fuller et al., 2000a, 2000b; Haws and Lux,
1990; Nosten et al., 1993; Vaseghi et al., 2013; Yue et al.,
2004). The ARI directly correlates with the duration be-
tween the times of steepest transmembrane AP upstroke
and downstroke (Chinushi et al., 2001; Fuller et al.,
2000b; Haws and Lux, 1990). The steepest portion of phase
3 AP repolarization reflects the timing of APD50 and is ex-
pressed in local electrograms (field potentials) as the time
of steepest upstroke of the Twave. Thus, ARImeasurements
have a direct correlate with transmembrane APs (i.e.,
APD50) in cells local to the recording electrode, as opposed
to field potential duration, a global assessment that reflects
the time at which all cells across the electrode array have re-
polarized. Based on our work here and published elsewhere
(Ajijola et al., 2013; Chinushi et al., 2001; Compton et al.,
1996; Fuller et al., 2000a, 2000b; Haws and Lux, 1990; Nos-
ten et al., 1993; Vaseghi et al., 2013; Yue et al., 2004), wem Cell Reports j Vol. 3 j 131–141 j July 8, 2014 j ª2014 The Authors 135
Figure 5. Electrophysiological Properties
of hiPSC CMs as Measured Using a 60-
Electrode MEA Chamber
(A) Left, image of the 60-electrode MEA
system, plated with monolayer of hiPSC CM.
Superimposed on the image are the indi-
vidual electrograms recorded at each elec-
trode position. Center-left view is an
example of methodology used to calculate
the ARI. Green trace represents a single
beat recorded at one lead of the MEA,
showing depolarization and repolarization
complexes, reminiscent of QRS and T waves.
The ARI is calculated as time between the
minimum first derivative of voltage (dV/dt)
in the depolarization wave and the time of
maximum dV/dt near the peak of the repo-
larization wave (bounded by the yellow
lines). Blue trace represents dV/dt curve of
the repolarization wave, used to determine
maximum dV/dt. Center-right view shows
example traces of consecutive spontaneous
beats recorded at a single MEA site. ARIs for
each lead were averaged to obtain a mean
ARI value at each site for the duration of the
recording. Right view is a representative electrogram recorded under control conditions and after perfusion with 10 and 100 nM dofetilide.
Note the prolongation of the repolarization wave with increasing concentrations of dofetilide.
(B) Isochronal time maps from a typical MEA chamber demonstrating AT (Act) across the array, ARI (a surrogate for APD), and conduction
velocity (CV). Act and ARI are reported in ms. CV is reported as cm/s.
(C) CMs differentiated from three different iPSC lines (C1, C6, and C7) exhibit similar electrophysiological properties. Box plots show mean
(square), SEM (box), SD (error bars), and 95% confidence intervals (crosshatch). No significant differences were detected within cell lines
with respect to the ARI, cycle length, and conduction velocity (n = 10–13 independent recordings).
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tion to most accurately define in vitro repolarization in
MEA analyses of iPSC CMs.
Finally, here, we report the application of hiPSC CM to a
powerful model system for the study of arrhythmia suscep-
tibility and mechanisms based on a tachypacing system
pioneered for use in an atrial tumor cell line. Rapid stimula-
tion (in vitro tachypacing) of cultured HL-1 atrial myocytes
induces acute electrical remodeling similar to that reported
from in vivo tachypacing models and human atrial
arrhythmia (Brundel et al., 2001, 2004, 2006; Ke et al.,
2011; Mace et al., 2009; Qi et al., 2008; Yang et al., 2005).
The hallmark of electrical remodeling is an abrupt reduc-
tion in L-type Ca2+ current as a consequence of downregu-
lation of Cav1.2 mRNA and proteins (Shiroshita-Takeshita
et al., 2005). Likewise, we observed an acute decrease in
CaTamplitude and Cav1.2 mRNA in response to rapid elec-
trical stimulation, supporting the notion that hiPSC CMs
also undergo acute electrical remodeling. It is worth noting
that our cells are heterogeneous in nature, encompassing a
mixture of nodal-, atrial-, and ventricular-like cells. Despite
this caveat, our study provides a preliminary description of136 Stem Cell Reports j Vol. 3 j 131–141 j July 8, 2014 j ª2014 The Authorsacute electrical remodeling in hiPSC-derived myocardial
cells. Future studies will characterize in detail themolecular
processes that underlie acute electrical remodeling in iPSC
CMs linked to acquired and/or inheritable human diseases.
Limitations
Several limitations are inherent to any hiPSC-CM study,
given the current state of research in this field. Although
efforts are ongoing to bias differentiation into chamber-
specific lineages (Zhang et al., 2011), there is currently
no established method for separating iPSC CMs into
atrial- or ventricular-specific subgroups. Moreover, the
designation of nodal-, atrial-, and ventricular-like CMs is
somewhat arbitrary, based on qualitative analysis of AP
waveforms, thus further complicating methods to isolate
chamber-specific lineages. Purification of atrial- or ventric-
ular-specific cell lines is necessary to advance the study
of chamber-specific diseases, such as atrial fibrillation or
ventricular tachycardia. The relatively immature nature of
hiPSC CMs is also a limitation of this model system,
complicating extrapolation to disease mechanism in adult
myocardium. Recent reports indicate that increasing the
Figure 6. The Electrophysiological Effects of Various Antiarrhythmic Agents on CMs Differentiated from Human PBMC-Derived
iPSCs
hiPSC-CM monolayers plated on MEA chambers were perfused with sequential concentrations of LIDO, dofetilide (DOF), diltiazem (DILT),
and amiodarone (AMIO). The ARI, conduction velocity, and cycle length were measured. *p < 0.05, calculated using repeated-measures
ANOVA with Bonferroni correction. CTRL, control; WASH, washout. n = 10 (LIDO and DOF) and 9 (DILT and AMIO) independent experiments.
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chenko et al., 2013). Finally, an important limitation was
our inability to pace hiPSC CMs when cultured on the
MEA chamber. Thus, we were unable to characterize the
relationship between cycle length and the ARI to deter-
mine whether cycle length correction is necessary in this
model system. APD of individual myocytes shortens with
faster cycle lengths (unpublished data), and thus, we spec-
ulate that a rate correction factor for MEA analyses is neces-
sary to precisely determine drug effects on repolarization in
the setting of altered spontaneous cycle lengths.Conclusions
In summary, our data indicate that electrophysiological
properties and pharmacological responses of PBMC-
derived iPSC CMs are generally similar to those of iPSC
CMs derived from other somatic cells, suggesting that
epigenetic memory may not play an important functional
role in iPSC CMs. We also show that CMs differentiated
from distinct iPSC lines from a single patient displayStesimilar electrophysiological features and pharmacological
responses. Finally, we demonstrate that hiPSC CMs un-
dergo acute changes in calcium-handling properties and
gene expression in response to rapid electrical stimulation,
laying the foundation for an in-vitro-tachypacing model
system for the study of human tachyarrhythmias.EXPERIMENTAL PROCEDURES
hiPSC Generation and CM Differentiation
All human subject research was approved by the University of
Utah institutional reviewboard. After obtaining informed consent,
peripheral blood was obtained from a 25-year-old Caucasian male
(patienthB53), andPBMCswere isolatedbydensitygradient centri-
fugation (So et al., 2013). To induce reprogramming and increase
the infection efficiency of PBMCs, cells were infected with lentivi-
ruses expressing OCT4, KLF4, SOX2, and c-MYC from a polycis-
tronic cassette (pHAGE2-TetOminiCMV-hSTEMCCA) (Sommer
et al., 2010; Staerk et al., 2010). We employed two rounds of lenti-
viral spin infection (day 9 and day 10) inwhich PBMCswere simul-
taneously infected with constitutively active lentiviruses encodingm Cell Reports j Vol. 3 j 131–141 j July 8, 2014 j ª2014 The Authors 137
Figure 7. Rapid Electrical Stimulation Reduces Ca2+ Transients and Cav1.2 Expression in hiPSC CM
(A) Representative Ca2+ transients recorded using fluo-4-labeled hiPSC CMs unpaced (CTRL) and paced at 1 or 4 Hz for 8 hr. Note the
abnormal secondary Ca2+ release during decay phase (inset).
(B) Bar graphs showing magnitude of Ca2+ transient expressed as F/F0 and rate of transient decay (tau, ms). *p < 0.0001 compared to 1 Hz
and CTRL. n = 10 independent recordings, each group.
(C) Cav1.2 expression, measured by RT-qPCR, in hiPSC CMs subjected to 1 and 4 Hz electrical stimulation.
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et al., 2008) and the STEMCCA vector. Infected blood cells were
transferred onto mouse embryonic fibroblast (MEF) feeder cells
3 days postinfection and cultured for an additional 7 days in MEF
medium supplemented with 10 ng/ml basic human fibroblast
growth factor, 5 mg/ml ascorbic acid, and 2 mg/ml doxycycline.
Following the appearance of small colonies, the medium was
changed to human ESC medium: Dulbecco’s modified Eagle’s
medium/F12 supplemented with GlutaMAX, 10 mM NEAA,
25 U/ml penicillin, 25 mg/ml streptomycin, 100 mM b-mercaptoe-
thanol, and 20% knockout serum replacement (Invitrogen) with
10 ng/ml basic fibroblast growth factor and 2 mg/ml doxycycline.
Colonieswere selected and expanded around day 30 postinfection.
After three passages on MEF feeder cells, the iPSC clones were
transferred to Matrigel (BD Biosciences; #354277)-coated dishes,
cultured, andexpanded inmTeSR1according to themanufacturer’s
protocol and gradually tapered from doxycycline.
CM differentiation was achieved by the matrix sandwich
method developed by Kamp and colleagues (Zhang et al., 2012;
J. Zhang et al., 2010, Circulation, abstract). The iPSCs were grown
as amonolayer in an artificial extracellularmatrix and sequentially
treated with growth factors known to be involved in early
embryonic heart development (activin A and bone morphogenic
protein-4) (Zhu et al., 2011). In practice, the iPSCs were seeded as
a monolayer on Matrigel-coated dishes in mTeSR1 (or Essential
8), followed by a Matrigel overlay in RPMI plus B27 (-insulin) (In-
vitrogen) medium, and sequential treatment with activin A, bone
morphogenic protein-4, and basic human fibroblast growth factor.
Quantitative Real-Time PCR
Total mRNA was harvested from PBMCs, iPSC clones, and con-
tracting hiPSC CMs (Ambion; PureLink RNA Kit), and cDNA was
synthesized (Applied Biosystems; High-Capacity cDNA Reverse
Transcription Kit). Gene expression was quantified by RT-qPCR us-
ing primers (see Tables S1 and S2) and SYBRGreen fromQIAGEN in
an Applied Biosystems 7900HT thermocycler. Expression levels
were normalized to 18S rRNA.
Immunocytochemistry
Immunocytochemistry was performed on iPSCs or hiPSC CMs
using standard protocols with the primary antibodies listed in138 Stem Cell Reports j Vol. 3 j 131–141 j July 8, 2014 j ª2014 The AuthorsTable S3. Cells were incubated with the following secondary anti-
bodies: Alexa Fluor 555 donkey anti-mouse or anti-rabbit immuno-
globulin G (IgG) (1:2,000; Invitrogen); Alexa Fluor 488 donkey
anti-rabbit IgG (1:2,000; Invitrogen); and Alexa Fluor 488 goat
anti-mouse IgG (1:2,000; Invitrogen). Nuclei were detected with
DAPI (Vector Laboratories; VECTASHIELD H-1200).
Teratoma Formation and Analysis
Teratomas were generated by injecting undifferentiated iPSCs into
nonobese diabetic severe combined immunodeficiency (SCID)
mice. Undifferentiated iPSCs were dissociated into single cells,
and approximately 1.5 million cells were injected into the testis
and/or the gastrocnemius muscle of the mice. Teratomas were
collected 4–8 weeks postinjection, then fixed with 10% zinc
formalin and embedded in paraffin.
Karyotype Analysis
Karyotype analysis was performed at ARUP Laboratories (Salt Lake
City). The iPSCs (at 70% confluence) were collected in hypotonic
potassium chloride (KCl) solution, fixed in methanol:glacial acid
3:1, plated on microscope slides, then stained with Leishman’s
stain. Metaphase spreads for each sample were analyzed.
Flow Cytometry
Enzymatically dissociated iPSCs were blocked, then reconstituted
in fluorescence-activated cell sorting (FACS) buffer (PBS plus 5%
fetal calf serum) containing the primary antibodies listed in the
Table S3. For secondary staining, cells were resuspended in FACS
buffer containing 1:500 diluted Alexa Fluor 488 and/or Alexa Fluor
647-conjugated antibodies (Invitrogen; #A11017 or #A31573,
respectively). Flow cytometry was performed on a BD Biosciences
FACSCanto II using 488 and 635 nm lasers. Data analysis was
done with FlowJo (TreeStar). Isotype controls were used to set gates




Spontaneously beating hiPSC CMs from patient hB53 (days 30–50
postdifferentiation) were studied. Cells were plated at low density
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Functional Analysis of iPSC Cardiomyocytesto increase the likelihood of observing single, beating myocytes.
All experiments were performed at 37C. The recording chamber
was superfused with a buffered, physiological solution containing
126 mmol/l NaCl, 4.4 mmol/l KCl, 1.1 mmol/l CaCl2, 1 mmol/l
MgCl2, 11 mmol/l glucose, and 24 mmol/l HEPES (pH 7.4 with
NaOH). Electrodes made from borosilicate capillary tubes (#8250
capillary glass; A-M Systems) were fire polished to obtain resis-
tances of 6–9 MU filled with internal solution containing
120 mmol/l KCl, 5 mmol/l EGTA, 5 mmol/l K2ATP, 5 mmol/l
MgCl2, and 10 mmol/l HEPES (pH 7.2).
Transmembrane potential (Vm) was measured by using an
AxoClamp 2A amplifier (Molecular Devices) in the bridge mode
with the disrupted patch technique. Vm was filtered at 10 kHz
and digitized at a sampling frequency of 20 kHz with a 12-bit
analog-to-digital converter (Digidata 1322A Interface; Molecular
Devices). The following AP parameters were analyzed: MDP, peak
maximum upstroke velocity, amplitude, and APD. APD was calcu-
lated as the time interval between the peak maximum upstroke
velocity (phase 0) and the time at 10% (APD10), 50% (APD50),
and 90% (APD90) of repolarization.
Recording of Extracellular Field Potential from Monolayers of
hiPS-CM
To characterize the electrophysiological properties of hiPSC CMs,
the cells were plated onto a MEA recording chamber (MEA60-Sys-
tem; Multi Channel Systems) treated with fibronectin. Each MEA
chamber consisted of 60 surface electrodes, with a recording field
of 1.43 1.4mm.Cells were superfusedwith buffered physiological
solution (see above) at 37C. Spontaneous extracellular field
potentials were recorded (5 kHz/channel sampling rate) from elec-
trodes across the array.
Local APD at each electrode was estimated bymeasuring the ARI.
The utility of the ARI as a surrogate for APD has been extensively
validated in animal models and human studies (Chinushi et al.,
2001; Fuller et al., 2000a; Haws and Lux, 1990; Yue et al., 2004)
using simultaneously acquired intracellular recordings and mono-
phasic APD recordings. In each electrogram, AT was measured as
the time of minimum first derivative of voltage (dV/dt) in the de-
polarization wave and repolarization time measured as the time
of maximum dV/dt near the peak of the repolarization wave. The
ARI was measured as the difference between repolarization and
ATs and reflects the local APD at the electrode site. Data from all
channels were analyzed using a custom-written program with a
graphic user interface. Color-coded isochronal maps were con-
structed using a standard 2D plotting routine based on the local
ATs between electrodes. Conduction velocity vectors were calcu-
lated at each individual electrode, and the average conduction
speed in themonolayer was calculated from the individual velocity
vectors as the mean of the conduction speed (magnitude of veloc-
ity vector).
In order to assess the quality of the MEA data, we plotted the cu-
mulative probability distribution functions (CPDFs) of AT and ARI
values for each spontaneous beat (typically 12–20 beats/recording)
in each of the 60 electrograms. These plots allow for an assessment
of the quality of the data by highlighting outlier measurements
that might skew the average calculation (Figure S1). A steep slope
of the CPDF relationship indicates that values for all beats were
very similar, whereas a shallow slope indicates a wide variationStein measured parameters. We calculated the average AT and ARI
value while excluding 20% of the measurements at the extremes.
Pharmacological Evaluation Using MEA Recordings
Electrophysiological effects of antiarrhythmic agents including
diltiazem, amiodarone, dofetilide, and LIDO on CMs cultured in
monolayers were evaluated using the MEA system. Dose-response
experiments were repeated in triplicate for three different hiPS-CM
lines generated from patient hB53. The hiPSC CMs were super-
fused with buffered physiological solution at 37C containing
increasing concentrations of the study drug while spontaneous
extracellular field potentials were recorded. The cells were perfused
with the study drug for 5 min to achieve quasi-steady state before
acquiring data.
Measurement of Intracellular Calcium
CaTs were detected in hiPSC CMs with an epifluorescence system
using the fluorescent indicator fluo-4 AM (Molecular Probes). De-
tails are described in the Supplemental Experimental Procedures.
Rapid Electrical Stimulation of hiPSC CM in Culture
Small clusters of spontaneous contractinghiPSCCMswere isolated
andmaintained in RPMI plus B27 (+insulin)media, then plated on
six cell culture dishes. Cells were electrically stimulated using car-
bon electrodes immersed in the culture media (C-Dish; IonOptix),
connected to a custom-built electrical stimulator via a ribbon ca-
ble. This system allowed for cells to be electrically stimulatedwhile
housed inside the incubator. Cells were electrically paced at 1 and
4Hz for 8 hr, using bipolar square-wave pulses of 5–15ms duration
and an amplitude of 20 V. To ensure effective ‘‘capture’’ of pacing,
current and pulse durationwere adjusted until visible contractions
were synchronous with the pacing frequency. Effective capture
was reassessed visually throughout the stimulation period.
Statistics
Differences in electrophysiological parameters in response to
increasing concentrations of antiarrhythmic agents were tested
using repeated-measures ANOVA (SYSTAT 13; Systat Software)
and the Bonferroni correction. Nonpaired measurement differ-
ences were tested using ANOVA. A p value <0.05 was required for
statistical significance.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, three figures, and three tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2014.04.017.
AUTHOR CONTRIBUTIONS
M.R., C.J.J., R.L.L., A.P.M., K.W.S., M.T.-F., and I.J.B. designed ex-
periments. M.R., C.J.J., S.L., A.P.M., K.W.S., E.C., and M.T.-F. per-
formed experiments and analyzed data. R.L.L. analyzed data.
M.R., C.J.J., M.T.-F., and I.J.B. wrote the paper.
ACKNOWLEDGMENTS
This work was supported by the Nora Eccles Treadwell Foundation
(to M.T.-F., K.W.S., and A.P.M.), the American Heart Associationm Cell Reports j Vol. 3 j 131–141 j July 8, 2014 j ª2014 The Authors 139
Stem Cell Reports
Functional Analysis of iPSC Cardiomyocytes(to C.J.J.), the NHLBI 2009 NIH Director’s Pioneer Award 7 DP1
HL117650-05 (to I.J.B.), VA Merit Review Award (to I.J.B.), NHLBI
5R01HL074370-04 (to I.J.B.), and NIH Merit Award R37
HL042873-24 (to K.W.S.).
Received: March 14, 2014
Revised: April 28, 2014
Accepted: April 29, 2014
Published: May 29, 2014REFERENCES
Ajijola, O.A., Yagishita, D., Patel, K.J., Vaseghi,M., Zhou,W., Yama-
kawa, K., So, E., Lux, R.L., Mahajan, A., and Shivkumar, K. (2013).
Focal myocardial infarction induces global remodeling of cardiac
sympathetic innervation: neural remodeling in a spatial context.
Am. J. Physiol. Heart Circ. Physiol. 305, H1031–H1040.
Braam, S.R., Tertoolen, L., Casini, S., Matsa, E., Lu, H.R., Teisman,
A., Passier, R., Denning, C., Gallacher, D.J., Towart, R., and Mum-
mery, C.L. (2013). Repolarization reserve determines drug re-
sponses in human pluripotent stem cell derived cardiomyocytes.
Stem Cell Res. (Amst.) 10, 48–56.
Brown, M.E., Rondon, E., Rajesh, D., Mack, A., Lewis, R., Feng, X.,
Zitur, L.J., Learish, R.D., and Nuwaysir, E.F. (2010). Derivation of
induced pluripotent stem cells from human peripheral blood T
lymphocytes. PLoS ONE 5, e11373.
Brundel, B.J., Van Gelder, I.C., Henning, R.H., Tuinenburg, A.E.,
Wietses, M., Grandjean, J.G., Wilde, A.A., Van Gilst, W.H., and
Crijns, H.J. (2001). Alterations in potassium channel gene expres-
sion in atria of patients with persistent and paroxysmal atrial fibril-
lation: differential regulation of protein and mRNA levels for K+
channels. J. Am. Coll. Cardiol. 37, 926–932.
Brundel, B.J., Kampinga, H.H., and Henning, R.H. (2004). Calpain
inhibition prevents pacing-induced cellular remodeling in a HL-1
myocytemodel for atrial fibrillation. Cardiovasc. Res. 62, 521–528.
Brundel, B.J., Henning, R.H., Ke, L., van Gelder, I.C., Crijns, H.J.,
and Kampinga, H.H. (2006). Heat shock protein upregulation pro-
tects against pacing-induced myolysis in HL-1 atrial myocytes and
in human atrial fibrillation. J. Mol. Cell. Cardiol. 41, 555–562.
Chinushi, M., Tagawa, M., Kasai, H., Washizuka, T., Abe, A., Fur-
ushima, H., and Aizawa, Y. (2001). Correlation between the effec-
tive refractory period and activation-recovery interval calculated
from the intracardiac unipolar electrogram of humans with and
without dl-sotalol treatment. Jpn. Circ. J. 65, 702–706.
Churko, J.M., Burridge, P.W., and Wu, J.C. (2013). Generation of
human iPSCs from human peripheral bloodmononuclear cells us-
ing non-integrative Sendai virus in chemically defined conditions.
Methods Mol. Biol. 1036, 81–88.
Compton, S.J., Lux, R.L., Ramsey, M.R., Strelich, K.R., Sanguinetti,
M.C., Green, L.S., Keating, M.T., and Mason, J.W. (1996). Geneti-
cally defined therapy of inherited long-QT syndrome. Correction
of abnormal repolarization by potassium. Circulation 94, 1018–
1022.
Fuller, M.S., Sa´ndor, G., Punske, B., Taccardi, B., MacLeod, R.S.,
Ershler, P.R., Green, L.S., and Lux, R.L. (2000a). Estimates of
repolarization and its dispersion from electrocardiographic140 Stem Cell Reports j Vol. 3 j 131–141 j July 8, 2014 j ª2014 The Authorsmeasurements: direct epicardial assessment in the canine heart.
J. Electrocardiol. 33, 171–180.
Fuller, M.S., Sa´ndor, G., Punske, B., Taccardi, B., MacLeod, R.S.,
Ershler, P.R., Green, L.S., and Lux, R.L. (2000b). Estimates of repo-
larization dispersion from electrocardiographic measurements.
Circulation 102, 685–691.
Haws, C.W., and Lux, R.L. (1990). Correlation between in vivo
transmembrane action potential durations and activation-recov-
ery intervals from electrograms. Effects of interventions that alter
repolarization time. Circulation 81, 281–288.
Hockemeyer, D., Soldner, F., Cook, E.G., Gao, Q., Mitalipova, M.,
and Jaenisch, R. (2008). A drug-inducible system for direct reprog-
ramming of human somatic cells to pluripotency. Cell StemCell 3,
346–353.
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winter-
stern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H.,
et al. (2011). Modelling the long QT syndrome with induced
pluripotent stem cells. Nature 471, 225–229.
Itzhaki, I., Maizels, L., Huber, I., Gepstein, A., Arbel, G., Caspi, O.,
Miller, L., Belhassen, B., Nof, E., Glikson, M., and Gepstein, L.
(2012). Modeling of catecholaminergic polymorphic ventricular
tachycardia with patient-specific human-induced pluripotent
stem cells. J. Am. Coll. Cardiol. 60, 990–1000.
Ivashchenko, C.Y., Pipes, G.C., Lozinskaya, I.M., Lin, Z., Xiaoping,
X., Needle, S., Grygielko, E.T., Hu, E., Toomey, J.R., Lepore, J.J., and
Willette, R.N. (2013). Human-induced pluripotent stem cell-
derived cardiomyocytes exhibit temporal changes in phenotype.
Am. J. Physiol. Heart Circ. Physiol. 305, H913–H922.
Kato, R., Venkatesh, N., Kamiya, K., Yabek, S., Kannan, R., and
Singh, B.N. (1988). Electrophysiologic effects of desethylamiodar-
one, an active metabolite of amiodarone: comparison with amio-
darone during chronic administration in rabbits. Am. Heart J.
115, 351–359.
Ke, L., Meijering, R.A., Hoogstra-Berends, F., Mackovicova, K., Vos,
M.J., Van Gelder, I.C., Henning, R.H., Kampinga, H.H., and Brun-
del, B.J. (2011). HSPB1, HSPB6, HSPB7 and HSPB8 protect against
RhoA GTPase-induced remodeling in tachypaced atrial myocytes.
PLoS ONE 6, e20395.
Kodama, I., Kamiya, K., Honjo, H., and Toyama, J. (1996). Acute
and chronic effects of amiodarone on mammalian ventricular
cells. Jpn. Heart J. 37, 719–730.
Kodama, I., Kamiya, K., and Toyama, J. (1997). Cellular electro-
pharmacology of amiodarone. Cardiovasc. Res. 35, 13–29.
Lahti, A.L., Kujala, V.J., Chapman, H., Koivisto, A.P., Pekkanen-
Mattila, M., Kerkela¨, E., Hyttinen, J., Kontula, K., Swan, H., Con-
klin, B.R., et al. (2012). Model for long QT syndrome type 2 using
human iPS cells demonstrates arrhythmogenic characteristics in
cell culture. Dis. Model. Mech. 5, 220–230.
Liang, P., Lan, F., Lee, A.S., Gong, T., Sanchez-Freire, V., Wang, Y.,
Diecke, S., Sallam, K., Knowles, J.W., Wang, P.J., et al. (2013).
Drug screening using a library of human induced pluripotent
stem cell-derived cardiomyocytes reveals disease-specific patterns
of cardiotoxicity. Circulation 127, 1677–1691.
Lowry, W.E., Richter, L., Yachechko, R., Pyle, A.D., Tchieu, J., Srid-
haran, R., Clark, A.T., and Plath, K. (2008). Generation of human
Stem Cell Reports
Functional Analysis of iPSC Cardiomyocytesinduced pluripotent stem cells from dermal fibroblasts. Proc. Natl.
Acad. Sci. USA 105, 2883–2888.
Mace, L.C., Yermalitskaya, L.V., Yi, Y., Yang, Z., Morgan, A.M., and
Murray, K.T. (2009). Transcriptional remodeling of rapidly stimu-
latedHL-1 atrialmyocytes exhibits concordancewith human atrial
fibrillation. J. Mol. Cell. Cardiol. 47, 485–492.
Malan, D., Friedrichs, S., Fleischmann, B.K., and Sasse, P. (2011).
Cardiomyocytes obtained from induced pluripotent stem cells
with long-QT syndrome 3 recapitulate typical disease-specific fea-
tures in vitro. Circ. Res. 109, 841–847.
Matsa, E., Rajamohan, D., Dick, E., Young, L., Mellor, I., Staniforth,
A., and Denning, C. (2011). Drug evaluation in cardiomyocytes
derived from human induced pluripotent stem cells carrying a
long QT syndrome type 2 mutation. Eur. Heart J. 32, 952–962.
Moretti, A., Bellin, M., Welling, A., Jung, C.B., Lam, J.T., Bott-Flu¨-
gel, L., Dorn, T., Goedel, A., Ho¨hnke, C., Hofmann, F., et al.
(2010). Patient-specific induced pluripotent stem-cell models for
long-QT syndrome. N. Engl. J. Med. 363, 1397–1409.
Navarrete, E.G., Liang, P., Lan, F., Sanchez-Freire, V., Simmons, C.,
Gong, T., Sharma, A., Burridge, P.W., Patlolla, B., Lee, A.S., et al.
(2013). Screening drug-induced arrhythmia events using human
induced pluripotent stem cell-derived cardiomyocytes and low-im-
pedance microelectrode arrays. Circulation 128 (Suppl 1), S3–S13.
Nosten, F., ter Kuile, F.O., Luxemburger, C., Woodrow, C., Kyle,
D.E., Chongsuphajaisiddhi, T., and White, N.J. (1993). Cardiac
effects of antimalarial treatment with halofantrine. Lancet 341,
1054–1056.
Qi, X.Y., Yeh, Y.H., Xiao, L., Burstein, B., Maguy, A., Chartier, D.,
Villeneuve, L.R., Brundel, B.J., Dobrev, D., and Nattel, S. (2008).
Cellular signaling underlying atrial tachycardia remodeling of
L-type calcium current. Circ. Res. 103, 845–854.
Shiroshita-Takeshita, A., Brundel, B.J., and Nattel, S. (2005). Atrial
fibrillation: basic mechanisms, remodeling and triggers. J. Interv.
Card. Electrophysiol. 13, 181–193.
So, E.C., Sallin, M.A., Zhang, X., Chan, S.L., Sahni, L., Schulze,
D.H., Davila, E., Strome, S.E., and Jain, A. (2013). A high
throughput method for enrichment of natural killer cells and
lymphocytes and assessment of in vitro cytotoxicity. J. Immunol.
Methods 394, 40–48.
Sommer, C.A., Sommer, A.G., Longmire, T.A., Christodoulou, C.,
Thomas, D.D., Gostissa, M., Alt, F.W., Murphy, G.J., Kotton,
D.N., and Mostoslavsky, G. (2010). Excision of reprogramming
transgenes improves the differentiation potential of ips cells
generated with a single excisable vector. Stem Cells 28, 64–74.
Sommer, A.G., Rozelle, S.S., Sullivan, S., Mills, J.A., Park, S.M.,
Smith, B.W., Iyer, A.M., French, D.L., Kotton, D.N., Gadue, P.,
et al. (2012). Generation of human induced pluripotent stem cells
from peripheral blood using the STEMCCA lentiviral vector. J. Vis.
Exp. 68, 4327.SteSpitzer, K.W., Sato, N., Tanaka, H., Firek, L., Zaniboni, M., and
Giles, W.R. (1997). Electrotonic modulation of electrical activity
in rabbit atrioventricular node myocytes. Am. J. Physiol. 273,
H767–H776.
Staerk, J., Dawlaty, M.M., Gao, Q., Maetzel, D., Hanna, J., Sommer,
C.A., Mostoslavsky, G., and Jaenisch, R. (2010). Reprogramming of
human peripheral blood cells to induced pluripotent stem cells.
Cell Stem Cell 7, 20–24.
Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent
stem cells from mouse embryonic and adult fibroblast cultures
by defined factors. Cell 126, 663–676.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T.,
Tomoda, K., and Yamanaka, S. (2007). Induction of pluripotent
stem cells from adult human fibroblasts by defined factors. Cell
131, 861–872.
Vaseghi, M., Yamakawa, K., Sinha, A., So, E.L., Zhou, W., Ajijola,
O.A., Lux, R.L., Laks, M., Shivkumar, K., and Mahajan, A. (2013).
Modulation of regional dispersion of repolarization and T-peak
to T-end interval by the right and left stellate ganglia. Am. J. Phys-
iol. Heart Circ. Physiol. 305, H1020–H1030.
Yang, Z., Shen, W., Rottman, J.N., Wikswo, J.P., and Murray, K.T.
(2005). Rapid stimulation causes electrical remodeling in cultured
atrial myocytes. J. Mol. Cell. Cardiol. 38, 299–308.
Yazawa, M., Hsueh, B., Jia, X., Pasca, A.M., Bernstein, J.A., Hall-
mayer, J., and Dolmetsch, R.E. (2011). Using induced pluripotent
stem cells to investigate cardiac phenotypes in Timothy syndrome.
Nature 471, 230–234.
Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J.,
Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart,
R., et al. (2007). Induced pluripotent stem cell lines derived from
human somatic cells. Science 318, 1917–1920.
Yue, A.M., Paisey, J.R., Robinson, S., Betts, T.R., Roberts, P.R., and
Morgan, J.M. (2004). Determination of human ventricular repo-
larization by noncontact mapping: validation with monophasic
action potential recordings. Circulation 110, 1343–1350.
Zhang, Q., Jiang, J., Han, P., Yuan, Q., Zhang, J., Zhang, X., Xu, Y.,
Cao, H., Meng, Q., Chen, L., et al. (2011). Direct differentiation of
atrial and ventricular myocytes from human embryonic stem cells
by alternating retinoid signals. Cell Res. 21, 579–587.
Zhang, J., Klos, M., Wilson, G.F., Herman, A.M., Lian, X., Raval,
K.K., Barron,M.R., Hou, L., Soerens, A.G., Yu, J., et al. (2012). Extra-
cellular matrix promotes highly efficient cardiac differentiation of
human pluripotent stem cells: the matrix sandwich method. Circ.
Res. 111, 1125–1136.
Zhu, W.Z., Van Biber, B., and Laflamme, M.A. (2011). Methods for
the derivation and use of cardiomyocytes fromhuman pluripotent
stem cells. Methods Mol. Biol. 767, 419–431.
Zwi, L., Caspi, O., Arbel, G., Huber, I., Gepstein, A., Park, I.H., and
Gepstein, L. (2009). Cardiomyocyte differentiation of human
induced pluripotent stem cells. Circulation 120, 1513–1523.m Cell Reports j Vol. 3 j 131–141 j July 8, 2014 j ª2014 The Authors 141
